Blay, J YHindi, NBollard, JAguiar, SAngel, MAraya, BBadilla, RBernabeu, DCampos, FCaro-Sanchez, C H SCarvajal, BCarvajal-Montoya, ACasavilca-Zambrano, SCastro-Oliden, VChacon, MClara, MCollini, PCorrea-Genoroso, RCosta, F DCuellar, MDei-Tos, A PDominguez-Malagon, H RDonati, DDufresne, AEriksson, MFarias-Loza, MFernandez, PFrezza, A MFrisoni, TGarcia-Ortega, D YGelderblom, HGouin, FGomez-Mateo, M CGronchi, AHaro, JHuanca, LJimenez, NKaranian, MKasper, BLopes-David, B BLopez-Pousa, ALutter, GMartinez-Said, HMartinez-Tlahuel, JMello, C AMorales-Perez, J MMoura-David, SNascimento, A GOrtiz-Cruz, E JPalmerini, EPatel, SPfluger, YProvenzano, SRighi, ARodriguez, ASalas, RSantos, T T GScotlandi, KSoule, TStacchiotti, SValverde, CWaisberg, FZamora Estrada, EMartin-Broto, J2023-05-032023-05-032021-11-13Blay JY, Hindi N, Bollard J, Aguiar S Jr, Angel M, Araya B, et al. SELNET clinical practice guidelines for soft tissue sarcoma and GIST. Cancer Treat Rev. 2022 Jan;102:102312http://hdl.handle.net/10668/22151Soft tissue sarcoma (STS) is a heterogeneous group of neoplasms, encompassing >80 different histologic subtypes. Approximately three quarters of sarcomas arise from soft tissue, about 15% are gastrointestinal stromal tumours (GISTs), and bone sarcomas represent the remaining 10%. The current guidelines will focus on soft tissue and GIST, excluding Kaposi sarcoma and non-pleomorphic rhabdomyosarcoma.enAttribution 4.0 Internationalhttp://creativecommons.org/licenses/by/4.0/Sarcoma, KaposiGastrointestinal Stromal TumorsSarcomaOsteosarcomaBone NeoplasmsRhabdomyosarcomaGastrointestinal Stromal TumorsGuidelines as TopicHumansLatin AmericaSarcomaSoft Tissue Neoplasmsresearch article34798363open accessSarcoma de KaposiRabdomiosarcomaNeoplasias cutáneasTumores del estroma gastrointestinalNeoplasias óseasSarcoma de Ewing10.1016/j.ctrv.2021.1023121532-1967http://www.cancertreatmentreviews.com/article/S0305737221001602/pdf